About
BioKier develops oral therapeutics that mimic the effects of bariatric-metabolic surgery to manage blood glucose and lipid levels in diabetes patients, supported by clinical studies and SBIR grants.
Explore BioKier's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.